Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene

Journal of AAPOS

Volumn 15, Issue 2, 2011, Pages 205-207

  Raiji, Veena Rao ^a   Miller, Marijean M ^a   Jung, L K ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISOLONE ACETATE; PREDNISONE; TRIAMCINOLONE;

ARTICLE; BLAU SYNDROME; CASE REPORT; CHILD; CONJUNCTIVAL BIOPSY; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SYNOVITIS; UVEITIS; VISION; VISUAL ACUITY;

CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 16; CRANIAL NERVE DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NOD2 SIGNALING ADAPTOR PROTEIN; PANUVEITIS; POINT MUTATION; SYNOVITIS; UVEITIS; VISUAL ACUITY;

EID: 79956218796     PISSN: 10918531     EISSN: 15283933     Source Type: Journal    
DOI: 10.1016/j.jaapos.2011.02.004     Document Type: Article

References (9)

1. Jabs DA, Houk JL, Bias WB, Arnett FC, et al. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med 1985;78:801-4. (Pubitemid 15008235)
2. Wang X, Kuivaniemi H, Bonavita G, Mutkus L, et al. CARD15 mutations in familial granulomatosis syndromes: A study of the original Blau syndrome kindred and other familieswith large-vessel arteritis and cranial neuropathy. Arthritis Rheum 2002;46:3041-5. (Pubitemid 35315899)
3. Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 2003;110:2040-44. (Pubitemid 37163327)
4. Rosenbaum JT, Planck SR, Davey MP, Iwanaga Y, Kurz DE, Martin TM. With a mere nod, uveitis enters a new era. Am J Ophthalmol 2003;136:729-32. (Pubitemid 37153190)
5. Arostegui J, Arnal C, Merino R, et al. NOD2 gene-associated pediatric granulomatous arthritis: Clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with Interleukin-1 blockade in a Spanish cohort. Arthritis and Rheumatism 2007;56:3805-13. (Pubitemid 350100713)
6. Chamaillard M, Philpott D, Girardin SE, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A 2003;100:3455-60. (Pubitemid 36356605)
7. Okafujim I, Nishikomori R, Kanazawa N, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arth Rheum 2009;60:242-50.
8. Ukae S, Tsutsumi H, Adachi N, Takahashi H, Kato F, Chiba S. Pre-school sarcoidosis manifesting as juvenile rheumatoid arthritis: A case report and a review of the literature of Japanese cases. Acta Paediatrica Japonica (Overseas Edition) 1994;36:515-8. (Pubitemid 24319574)
9. Kanazawa N, Okafuji I, Kambe N, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-B activation: Common genetic etiology with Blau syndrome. Blood 2005;105:1195-7. (Pubitemid 40170893)